Healthy Skepticism Library
Items published during the years 2000 to 2009
There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.
Page 20 of 144 pages ‹ First < 18 19 20 21 22 > Last ›
HSL14552
Global pharma market forecast to exceed $820bn in 2009
Manufacturing Chemist 2009
http://www.ims-japan.co.jp/pr_20081029.php
HSL14929
Tattersall MHN, Dimoska A, Gan K.
Patients expect transparency in doctors’ relationships with the pharmaceutical industry
eMJA 2009; 2:65-68
http://www.mja.com.au/public/issues/190_02_190109/tat10368_fm.html
HSL14930
Olver IN, Haines IE.
What changes are needed to the current direction and interpretation of clinical cancer research to meet the needs of the 21st century?
eMJA 2009; 190:(2):74-77
http://www.mja.com.au/public/issues/190_02_190109/olv10224_fm.html
HSL14946
Loukas E.
Sales Through Retail Pharmacies (Twelve months to November 2008*)
IMS 2009
http://view.respond.imshealth.com/?j=fe8a12757c66067471&m=fef31377726304&ls=fdf51577706d027d77137070&l=fe9c1570746204787
HSL14991
Sweet M.
Pharmaceutical marketing and the internet
Australian Prescriber 2009; 23:2-4
http://www.australianprescriber.com/magazine/32/1/2/4/
HSL15040
Stockigt JR.
The quality of medication information in Australia: the need for more clinical expertise and accountability
eMJA 2009; 190:(3):110-111
http://www.mja.com.au/public/issues/190_03_020209/sto11172_fm.html
HSL15045
Mansell P, Read J.
Posttraumatic stress disorder, drug companies, and the internet.
J Trauma Dissociation 2009; 10:(1):9-23
http://www.ncbi.nlm.nih.gov/pubmed/19197709
HSL15046
Alkhateeb FM, Khanfar NM, Clauson KA.
Characteristics of physicians who frequently see pharmaceutical sales representatives.
J Hosp Mark Public Relations 2009; 19:(1):2-14
http://www.ncbi.nlm.nih.gov/pubmed/19197653
HSL15047
Polen HH, Khanfar NM, Clauson KA.
Impact of Direct-to-Consumer Advertising (DTCA) on Patient Health-Related Behaviors and Issues.
Health Mark Q. 2009; 26:(1):42-55
http://www.ncbi.nlm.nih.gov/pubmed/19197587
HSL15165
Elshaug AG, Moss JR, Littlejohns P, Karnon J, Merlin TL, Hiller JE.
Identifying existing health care services that do not provide value for money
Med J Aust 2009; 190:(5):269-273
http://www.mja.com.au/public/issues/190_05_020309/ell10663_fm.html
HSL15177
PriceWaterhouseCoopers
Pharma 2020: Marketing the future: Which path will you take?
: PriceWaterhouseCoopers 2009
http://www.pwc.com/Extweb/pwcpublications.nsf/docid/B1221EC9D057309F852575610076732C
HSL15182
Aronson JK, Price D, Ferner RE
A strategy for regulatory action when new adverse effects of a licensed product emerge.
Drug Saf 2009; 32:(2):91-8
http://www.ncbi.nlm.nih.gov/pubmed/19236116?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
HSL15262
Leo J, Lacasse JR.
Consumer advertisements of medications for ADHD
Tamimi S, Leo J. Rethinking ADD: From Brain To Culture. New York: Palgrave Macmillan 2009
http://www.amazon.com/Rethinking-ADHD-Culture-Sami-Timimi/dp/0230507123
HSL15382
Abelson J, Collins PA.
Media Hyping and the 'Herceptin Access Story': An Analysis of Canadian and UK Newspaper Coverage
Healthcare Policy / Politiques de Santé 2009; 4:(3):e113-e128
http://www.longwoods.com/product.php?productid=20474&cat=582
HSL15505
Mulki JP, Jaramillo JF, Locander WB.
Critical Role of Leadership on Ethical Climate and Salesperson Behaviors
Journal of Business Ethics 2009; (86):125-141
http://www.springerlink.com/content/355705k570264364/
HSL15524
Jureidini J
How do we Safely Treat Depression in Children, Adolescents and Young Adults?
Drug Saf 2009; 32:(4):275-82
http://www.ncbi.nlm.nih.gov/pubmed/19388719
HSL15541
Rod M, Saunders S.
The informative and persuasive components of pharmaceutical
International Journal of Advertising 2009; 28:(2):313-349
http://www.internationaljournalofadvertising.com/
HSL15568
Manhattan Research
The Absolute, Relative, and Incremental ROI of DTC Digital Marketing
: Manhattan Research 2009
http://www.manhattanresearch.com/files/White_Papers/The_Absolute_Relative_and_Incremental_ROI_of_DTC_Digital_Marketing.pdf
HSL15625
Molnar FJ, Man-son-hing M, Hutton B, Fergusson DA.
Have last-observation-carried-forward analyses caused us to favour more toxic dementia therapies over less toxic alternatives? A systematic review
Open Medicine 2009; 3:(2):
http://www.openmedicine.ca/article/view/245/230
HSL15626
Altman DG.
Missing outcomes in randomized trials: addressing the dilemma
Open Medicine 2009; 3:(2):
http://www.openmedicine.ca/article/view/323/232
HSL15635
Food and Drug Administration
RE: NDA #20-449 Taxotere® (docetaxel) Injection Concentrate, Intravenous Infusion (IV)
: Food and Drug Administration 2009
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/UCM153134.pdf
HSL15700
Jureidini JN, McHenry LB.
Key Opinion Leaders and Paediatric Antidepressant Overprescribing
Psychotherapy and Psychosomatics 2009; 78:(4):197-201
http://www.online.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&ArtikelNr=214440&Ausgabe=248735&ProduktNr=223864&filename=214440.pdf
HSL15785
Vandereycken W.
[An analysis of advertisements for psychotropic drugs in the Dutch Journal of Psychiatry ('Tijdschrift voor Psychiatrie')].
Tijdschr Psychiatr. 2009; 51:(6):407-11
http://www.tijdschriftvoorpsychiatrie.nl/en/tijdschrift/artikel/TVPart_2796
HSL15786
Greene JA, Podolsky SH
Keeping modern in medicine: pharmaceutical promotion and physician education in postwar america.
Bull Hist Med 2009; 83:(2):331-77
http://muse.jhu.edu/journals/bulletin_of_the_history_of_medicine/v083/83.2.greene.html
HSL15834
Liang BA, Mackey T.
Searching for safety: addressing search engine, website, and provider accountability for illicit online drug sales.
Am J Law Med. 2009; 35:(1):125-84
http://www.ncbi.nlm.nih.gov/pubmed/19534258
HSL15881
Rojas M.
Price discrimination by pharmaceutical companies across Central American countries
International Journal of Pharmaceutical and Healthcare Marketing 2009; 3:(2):118 - 136
http://www.emeraldinsight.com/Insight/viewContentItem.do?contentType=Article&contentId=1796048
HSL15882
Kalyanaram GK.
The endogenous modeling of the effect of direct-to-consumer advertising in prescription drugs
International Journal of Pharmaceutical and Healthcare Marketing 2009; 3:(2):137 - 148
http://www.emeraldinsight.com/Insight/viewContentItem.do?contentType=Article&contentId=1796049
HSL15963
Greenland S.
Accounting for uncertainty about investigator bias: disclosure is informative: How could disclosure of interests work better in medicine, epidemiology and public health?
Journal of Epidemiology and Community Health 2009; 63:593-598
http://jech.bmj.com/cgi/content/extract/63/8/593?etoc
HSL15964
Michaels D.
Addressing conflict in strategic literature reviews: disclosure is not enough: How could disclosure of interests work better in medicine, epidemiology and public health?
J Epidemiol Community Health 2009; 63:599-600
http://jech.bmj.com/cgi/content/extract/63/8/599?etoc
HSL15965
Weed DL.
Conflicts of interest: How could disclosure of interests work better in medicine, epidemiology and public health?
J Epidemiol Community Health 2009; 63:(8):601-602
http://jech.bmj.com/cgi/content/extract/63/8/601?etoc
HSL15966
Spelsberg A, Martiny A, Schoenhoefer PS.
Is disclosure of potential conflicts of interest in medicine and public health sufficient to increase transparency and decrease corruption?: How could disclosure of interests work better in medicine, epidemiology and public health?
J Epidemiol Community Health 2009; 63:(8):603-605
http://jech.bmj.com/cgi/content/extract/63/8/603?etoc
HSL15967
Wagner W, McGarity T.
Regulatory reinforcement of journal conflict of interest disclosures: How could disclosure of interests work better in medicine, epidemiology and public health?
J Epidemiol Community Health 2009; 63:(8):606-607
http://jech.bmj.com/cgi/content/extract/63/8/606?etoc
HSL15968
Marcovitch H.
How do potential conflicts of interest confuse medicine and public health? How could disclosure of interests work better in medicine, epidemiology and public health?
J Epidemiol Community Health 2009; 63:(8):608-609
http://jech.bmj.com/cgi/content/extract/63/8/608?etoc
HSL15970
12th Annual Survey on Consumer Reaction to DTC Advertising of Prescription Drugs Reveals: Nearly 50% of Online Consumers Report Health Videos a Top Resource
Pharma Live 2009
http://pharmalive.com/news/index.cfm?articleID=638484
HSL15987
Bove AA.
President's Page: Relations With Industry: Thoughts on Claims of a Broken System
J Am Coll Cardiol 2009; 54:(2):177-179
http://content.onlinejacc.org/cgi/content/full/54/2/177
HSL16018
O'Meara A.
Chasing Medical Miracles - The Promise and Perils of Clinical Trials
: Walker Books 2009
http://www.walkerbooks.com/books/catalog.php?key=818
HSL16023
Glasziou PP.
Promoting evidence-based non-drug interventions: time for a non-pharmacopoeia?
MJA 2009; 191:(2):52-53
http://www.mja.com.au/public/issues/191_02_200709/gla10407_fm.html
HSL16024
Lexchin J.
CJEM and pharmaceutical advertisements: it’s time for an end
CJEM 2009; 11:(4):375-9
http://www.cjem-online.ca/v11/n4/p375
HSL16080
Limbu Y, Torres IM.
The effects of involvement and ad type on attitudes toward direct-to-consumer advertising of prescription drugs.
J Health Hum Serv Adm 2009 Sum; 32:(1):107-38
http://www.ncbi.nlm.nih.gov/pubmed/19558035
HSL16098
Rutherford BR, Sneed JR, Roose SP.
Does study design influence outcome? The effects of placebo control and treatment duration in antidepressant trials.
Psychother Psychosom 2009; 78:(3):172-81
http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=000209348
HSL16100
Kale SA, Barkin RL.
Resuscitation and rescue of the pharmaceutical detail: a prescriber-drug representative collaboration.
Compr Ther 2009 Sum; 35:(2):68-71
http://www.ncbi.nlm.nih.gov/pubmed/19618754
HSL16164
Martin JH, Beer C, Morris RG, Doogue MP.
Doctors and the pharmaceutical industry: time for a national policy?
MJA 2009; 191:(3):189-190
http://www.mja.com.au/public/issues/191_03_030809/letters_030809_fm-4.html
HSL16254
Taylor D
Branding Q&A
MedAdNews 2009
http://medad.canon-experts.com/expert/dale-taylor/
HSL16285
Wyeth Ghostwriting Archive
PLoS Med 2009;
http://www.plosmedicine.org/static/ghostwriting.action
HSL16459
Gérvas J, Mansfield PR
Physicians, the industry and population health
Journal of Epidemiology and Community Health 2009; 63:(10):773-774
http://jech.bmj.com/cgi/content/extract/63/10/773
HSL16469
Van Der Weyden MB
Confronting conflict of interest
eMJA 2009; 191:(5):241
http://www.mja.com.au/public/issues/191_05_070909/martin_070909.html
HSL16529
Gülöksüz S, Oral ET, Ulaş H.
[Attitudes and behaviors of psychiatry residents and psychiatrists working in training institutes towards the relationship between the pharmaceutical industry and physicians].
Turk Psikiyatri Derg 2009; 20:(3):236-42
http://www.turkpsikiyatri.com/ftr.aspx?id=714
HSL16557
Tipton M, Bharadwaj S, Robertson D
Regulatory Exposure of Deceptive Marketing and its Impact on Firm Value
Journal of Marketing 2009;
http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1431978
HSL16669
Kalb PE, Greenberg PE.
Legal and economic perspectives concerning US government investigations of alleged off-label promotion by drug manufacturers.
Pharmacoeconomics 2009; 27:(8):623-5
http://www.ncbi.nlm.nih.gov/pubmed/19835018
HSL16758
Egilman D
Just say no
BMJ 2009; 339:b4527
http://www.bmj.com/cgi/content/short/339/nov02_2/b4527?rss=1
HSL16769
Zinner DE, Bjankovic D, Clarridge B, Blumenthal D, Campbell EG
Participation Of Academic Scientists In Relationships With Industry
Health Affairs 2009; 28:(6):1814
http://content.healthaffairs.org/cgi/content/abstract/28/6/1814
HSL16810
Evidence and Recommendations for a Model PharmFree Curriculum
PharmFree 2009
http://www.pharmfree.org/tools/resources_documents/files/ModelPharmFreeCurriculum_Final.pdf
HSL16863
de Barros JA
Medicamentos: una contribución a la reflexión hacia su uso racional
RISAI 2009; 1:(3):1-5
http://pub.bsalut.net/cgi/viewcontent.cgi?article=1027&context=risai
HSL16887
Ghaemi SN
The failure to know what isn't known: negative publication bias with lamotrigine and a glimpse inside peer review
Evid Based Mental Health 2009; 12:(3):65
http://ebmh.bmj.com/content/12/3/65.full
HSL16925
The Royal Australian and New Zealand College of Psychiatrists
Symposium on Commercial Sponsorship of Psychiatrist Education
2009
http://ranzcp.cmsaustralasia.com/video.load.php?videosource=rtmp://ocy932wr.rtmphost.com/09175/Panel_LR.FLV
HSL16933
Sweet MA, Simons MJ
As mass media evolves into 'masses of media', what are the implications for our health?
Med J Aust 2009; 191:(11/12):618-619
http://www.mja.com.au/public/issues/191_11_071209/swe11253_fm.html
HSL16934
Chapman S, Holding SJ, Ellerm J, Heenan RC, Fogarty AS, Imison M, Mackenzie R, McGeechan K
The content and structure of Australian television reportage on health and medicine, 2005-2009: parameters to guide health workers
Med J Aust 2009; 191:(11/12):620-624
http://www.mja.com.au/public/issues/191_11_071209/cha10706_fm.html
HSL16935
Medicines Australia Code of Conduct: breaches
Aust Prescr 2009
http://www.australianprescriber.com/magazine/32/6/160/1/
HSL16937
Archontaki M, Symvoulakis EK, Hajiioannou JK, Stamou AK, Kastrinakis S, Bizaki AJ, Kyrmizakis DE.
Increased frequency of rhinitis medicamentosa due to media advertising for nasal topical decongestants.
B-ENT 2009; 5:(3):159-62
http://www.ncbi.nlm.nih.gov/pubmed/19902852
HSL17018
Sismondo S, Nicholson SH.
Publication planning 101.
J Pharm Pharm Sci 2009; 12:(3):273-9
http://ejournals.library.ualberta.ca/index.php/JPPS/article/viewFile/6299/5594
HSL17053
Idris KM, Yousif MA, Mustafa AF
Influence of pharmaceutical industry's promotion on the doctors' prescribing patterns in Sudan
The Journal of Medicine Use in Developing Countries 2009; 1:(3):3- 13
www.usm.my/dsap/journal/article/disember2009/Article2.pdf
HSL17201
Ball JG, Liang A, Lee WN.
Representation of African Americans in direct-to-consumer pharmaceutical commercials: a content analysis with implications for health disparities.
Health Mark Q 2009; 26:(4):372-90
http://www.ncbi.nlm.nih.gov/pubmed/19916100
HSL17202
Fogel J, Novick D.
Direct-to-consumer advertisements of prescription medications over the Internet.
Health Mark Q 2009; 26:(4):347-71
http://www.ncbi.nlm.nih.gov/pubmed/19916099
HSL17203
Bhutada NS, Cook CL, Perri M 3rd.
Consumers responses to coupons in direct-to-consumer advertising of prescription drugs.
Health Mark Q 2009; 26:(4):333-46
http://www.ncbi.nlm.nih.gov/pubmed/19916098?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=2
HSL17204
DeLorme DE, Huh J, Reid LN.
Direct-to-consumer advertising skepticism and the use and perceived usefulness of prescription drug information sources.
Health Mark Q 2009; 26:(4):293-314
http://www.ncbi.nlm.nih.gov/pubmed/19916096
HSL17205
Silver LS, Stevens RE, Loudon D.
Direct-to-consumer advertising of pharmaceuticals: concepts, issues, and research.
Health Mark Q 2009; 26:(4):251-8
http://www.ncbi.nlm.nih.gov/pubmed/19916093
HSL17354
Smith BD
An exploratory study of key opinion leadership management trends among European pharmaceutical companies
Journal of Medical Marketing 2009; 9:(4):291–300
http://www.palgrave-journals.com/jmm/journal/v9/n4/abs/jmm200931a.html
HSL17357
Michael Stros, Juerg Hari, John Marriott
The relevance of marketing activities in the Swiss prescription drugs market: Two empirical qualitative studies
International Journal of Pharmaceutical and Healthcare Marketing 2009; 3:(4):323 - 346
http://www.emeraldinsight.com/Insight/viewContentItem.do?contentType=Article&contentId=1826906
HSL17660
Goldacre B
Bad Science : HarperCollins 2009
http://www.harpercollins.co.uk/Titles/36492/bad-science-ben-goldacre-9780007284870
HSL17849
Villanueva T
Centro Vasco de Información de Medicamentos CEVIME-MIEZ
Rev Port Clin Geral 2009; 25:724
http://www.osanet.euskadi.net/r8520361/es/ contenidos/informacion/presentacion_cevime/ es_1219/indice_c.html
HSL18178
Fava GA
The Decline of Pharmaceutical Psychiatry and the Increasing Role of Psychological Medicine
Psychother Psychosom 2009; 78:(4):220-227
http://content.karger.com/produktedb/produkte.asp?doi=214443
HSL18637
Nelson DE, Hesse BW, Croyle RT
Making Data Talk: Communicating Public Health Data to the Public, Policy Makers, and the Press : Oxford University Press 2009
HSL18720
Herzberg D.
'Will wonder drugs never cease!': a prehistory of direct-to-consumer advertising.
Pharm Hist 2009; 51:(2):47-56
http://www.ncbi.nlm.nih.gov/pubmed/20853552
HSL19570
Bunniran S, McCaffrey DJ 3rd, Bentley JP, Bouldin AS.
Pharmaceutical product withdrawal: attributions of blame and its impact on trust.
Res Social Adm Pharm 2009; 5:(3):262-73
http://www.rsap.org/article/S1551-7411(08)00096-X/abstract
HSL14839
Singer N.
No Mug? Drug Makers Cut Out Goodies for Doctors
The New York Times 2008 Dec 31
http://www.nytimes.com/2008/12/31/business/31drug.html?hp
HSL14892
Santiago MG, Bucher HC, Nordmann AJ.
Accuracy of drug advertisements in medical journals under new law regulating the marketing of pharmaceutical products in Switzerland.
BMC Med Inform Decis Mak 2008 Dec 31; 8:(1):61
http://www.biomedcentral.com/1472-6947/8/61
HSL14874
Drug Researcher Agrees to Curb Role
The Wall Street Journal 2008 Dec 30
http://online.wsj.com/article_email/SB123068708012744467-lMyQjAxMDI4MzMwMTYzODE3Wj.html
HSL14875
Belluck P.
Child Psychiatrist to Curtail Industry-Financed Activities
The New York Times 2008 Dec 30
http://www.nytimes.com/2008/12/31/health/policy/31psych.html
HSL15076
Ripley K.
MERCOSUR Adopts Guidelines on Promotion, Advertising & Marketing of Pharmaceuticals
The TEMAS Blog 2008 Dec 30
http://www.temasactuales.com/temasblog/health-issues/mercosur-adopts-guidelines-on-promotion-advertising-marketing-of-pharmaceuticals/
HSL14876
Florida nets $8.5M in Medicaid settlement
Orlando Business Journal 2008 Dec 29
http://www.bizjournals.com/orlando/stories/2008/12/29/daily10.html
HSL14830
Sullivan L.
Novartis' Excedrin YouTube Contest Deemed A Success
Marketing Daily 2008 Dec 24
http://www.mediapost.com/publications/?fa=Articles.san&s=97211&Nid=50630&p=448587
HSL14870
Erdley D.
State pharmacist convicted of conflict of interest
Pittsburgh Tribune-Review 2008 Dec 24
http://www.pittsburghlive.com/x/pittsburghtrib/s_604288.html
HSL14871
Beard K.
Commentary: The balance between marketing and safety.
BMJ 2008 Dec 24; 337:a2996:
http://www.bmj.com/cgi/content/extract/337/dec24_1/a2996
HSL14872
FDA Sends Abbott Letter About Humira
PharmaLive 2008 Dec 24
http://pharmalive.com/news/index.cfm?articleID=594701
HSL15075
Ripley K.
New Brazilian Rules on Pharmaceutical Marketing
The TEMAS Blog 2008 Dec 24
http://www.temasactuales.com/temasblog/consumer-protection/new-brazilian-rules-on-pharmaceutical-marketing/
HSL14873
Edwards Lifesciences to Disclose Financial Relationships With U.S. Physicians
CNN Money.com 2008 Dec 23
http://www.edwards.com/newsroom/Pages/nr20081223.aspx
HSL17463
Pereira J
Emory Professor Steps Down
The Wall Street Journal 2008 Dec 23
http://online.wsj.com/article/SB123000405102929417.html
HSL14867
GSK to end state-level political contributions
Triangle Business Journal 2008 Dec 22
http://triangle.bizjournals.com/triangle/stories/2008/12/22/daily3.html
HSL14877
GlaxoSmithKline to Cease Providing Corporate Political Contributions
PharmaLive 2008 Dec 22
http://pharmalive.com/news/index.cfm?articleID=594315
HSL14884
Wilson D.
Publisher opens inquiry into article on Wyeth drug
The International Herald Tribune 2008 Dec 20
http://www.iht.com/articles/2008/12/20/technology/drugs.php
HSL14888
Clarke J, Gawley A.
The Triumph of Pharmaceuticals: The Portrayal of Depression from 1980 to 2005.
Adm Policy Ment Health. 2008 Dec 20;
http://www.springerlink.com/link.asp?id=bp5n771x127221g1
HSL14823
ISDB Statement on Direct-To-Consumer-Advertising (DTCA)
2008 Dec 19
HSL14837
Charter D.
AstraZeneca row as corruption claims engulf Nobel prize
The Times 2008 Dec 19
http://www.timesonline.co.uk/tol/news/world/europe/article5367941.ece
HSL14866
Wilson D.
Medical Publisher to Review Claim About Article’s Writer
The New York Times 2008 Dec 19
http://www.nytimes.com/2008/12/20/business/20ghost.html?_r=1
HSL14822
Anvisa aprova restrições para propagandas de medicamentos
JC OnLine (Recife, Brasil) 2008 Dec 18
http://jc.uol.com.br/2008/12/18/not_187695.php
HSL14833
Laidlaw S.
Nobel prize probe launched
thestar.com 2008 Dec 18
http://www.thestar.com/News/World/article/555701
HSL14834
Pfizer Again Tops Annual “Most Effective” Sales Force Ranking, According to Study by GfK Market Measures
Business Wire 2008 Dec 18
http://www.businesswire.com/portal/site/google/?ndmViewId=news_view&newsId=20081218005081&newsLang=en
HSL14831
Ramshaw E.
Filing alleges drug maker defrauded Texas to get on Medicaid list
The Dallas Morning News 2008 Dec 17
http://www.pharmalot.com/2008/12/johnson-johnson-texas-and-medicaid-fraud/
HSL14820
Roner L.
SFE in Australia – a conversation with Paul Hobbs
eyeforpharma.com 2008 Dec 16
http://web.archive.org/web/20101219160400/http://social.eyeforpharma.com/story/sfe-australia-%E2%80%93-conversation-paul-hobbs
HSL14826
Roner L.
Using CRM to meet the challenges of a rapidly changing healthcare
eyeforpharma.com 2008 Dec 16
http://social.eyeforpharma.com/story/using-crm-meet-challenges-rapidly-changing-healthcare-environment
Page 20 of 144 pages ‹ First < 18 19 20 21 22 > Last ›
